AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE APPLICATION OF NASAL EPINEPHRINE.
House Bill 466 amends Title 16 of the Delaware Code to enhance access to and use of intranasal epinephrine sprays in institutions of higher education, alongside existing provisions for epinephrine autoinjectors. The bill establishes definitions, guidelines for prescribing and dispensing these medications, and outlines training requirements for employees or agents of educational institutions. It aims to promote the safe use of epinephrine treatments to reduce fatalities from anaphylaxis in educational settings.
The bill impacts state laws by expanding the legal framework for the use of intranasal epinephrine sprays in addition to epinephrine autoinjectors in higher education institutions. It allows licensed healthcare providers to prescribe these medications in the name of educational institutions, thus facilitating their availability in emergencies. The bill also establishes immunity for healthcare providers, pharmacists, and institutions from liability when administering or dispensing these medications in good faith.
The sentiment around the bill appears to be generally supportive, as it addresses a critical health issue related to anaphylaxis in educational environments. However, specific discussions or votes on the bill were not documented, which may indicate a lack of contention or a straightforward passage process.
There are no notable points of contention reported in the discussions or voting history related to this bill. The lack of documented opposition suggests a consensus on the importance of enhancing access to life-saving medications in educational settings.